Company Biotech Acquisition Company
Equities
BIOT
KYG1125A1085
Investment Holding Companies
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Shleifer
CEO | Chief Executive Officer | 49 | - |
Thomas Fratacci
DFI | Director of Finance/CFO | 46 | 31/08/20 |
Ivan Jarry
COO | Chief Operating Officer | 45 | 31/08/20 |
Albert F. Hummel
CIO | Chief Investment Officer | 78 | 31/08/20 |
Tanguy Serra
PRN | Corporate Officer/Principal | 45 | 02/09/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Albert F. Hummel
CIO | Chief Investment Officer | 78 | 31/08/20 |
Bruno Montanari
BRD | Director/Board Member | 49 | 24/01/21 |
Paul D. Bernard
BRD | Director/Board Member | 55 | 24/01/21 |
Michael Shleifer
CEO | Chief Executive Officer | 49 | - |
Aaron Kim
BRD | Director/Board Member | 53 | 24/01/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,750,000 | 0 | 0 | 80.00 % |
Stock B | 1 | 23,000,000 | 23,000,000 ( 100.00 %) | 0 |
Company contact information
1st Jan change | Capi. | |
---|---|---|
+150.22% | 6.61B | |
+2.28% | 982M | |
+41.91% | 872M | |
+32.01% | 858M | |
+1.77% | 664M | |
+2.33% | 642M | |
-.--% | 600M | |
+3.61% | 503M | |
-.--% | 500M |